维普期刊资源整合服务平台（V6.5）

114篇 您的检索式：作者名="Dahabreh"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Ability of bone graft substitutes to support the osteoprogenitor cells: An in-vitro study显示文摘AIM: To compare seven commercially available bone graft substitutes(BGS) in terms of these properties and without using any additional biological growth factors.METHODS: Porcine osteoprogenitor cells were loaded on seven commercially available BGS and allowed to proliferate for one week followed by osteogenic induction. Staining for live/dead cells as well as scanning electron microscopy(SEM) was carried out to determine viability and cellular binding. Further outcome measures included alkaline phosphatase(ALP) assays with normalisation for DNA content to quantify osteogenic potential. Negative and positive control experiments were carried out in parallel to validate the results.RESULTS: Live/dead and SEM imaging showed higher viability and attachment with β-tricalcium phosphate(β-TCP) than with other BGS(P < 0.05). The average ALP activity in nmol/mL(normalised value for DNA content in nmol/μg DNA) per sample was 657.58(132.03) for β-TCP, 36.22(unable to normalise) for calcium sulphate, 19.93(11.39) for the Hydroxyapatite/Tricalcium Phosphate composite, 14.79(18.53) for polygraft, 13.98(8.15) for the highly porous β-Tricalcium Phosphate, 5.56(10.0) for polymers, and 3.82(3.8) for Hydroxyapatite.CONCLUSION: Under the above experimental conditions, β-TCP was able to maintain better the viability of osteoprogenitor cells and allow proliferation and differentiation(P < 0.05).	Ziad Dahabreh Michalis Panteli Ippokratis Pountos Mark Howard Peter Campbell Peter V Giannoudis	2014	World Journal of Stem Cells2014，6，4：	3
2	Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial显示文摘	Jean-Yves Douillard Rafael Rosell Mario De Lena Francesco Carpagnano Rodryg Ramlau Jose Luis Gonzáles-Larriba Tomasz Grodzki Jose Rodrigues Pereira Alain Le Groumellec Vito Lorusso Claude Clary Antonio J Torres Jabrail Dahabreh Pierre-Jean Souquet Julio A	2006	Lancet Oncology2006，，9：	2
3	Assessment of somatic K-ras mutations as a mechanism associated with resist- ance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic eolorectal cancer显示文摘	Linardou H Dahabreh IJ Kanaloupiti D	2008	Lancet Oncol2008，9，10：	1
4	A cost analysis of treatment of tibial fracture nonunion by bone grafting or bone morphogenetic protein-7显示文摘	Z. Dahabreh G. M. Calori N. K. Kanakaris V. S. Nikolaou P. V. Giannoudis	2009	International Orthopaedics2009，，5：	1
5	Trastuzumab in the adjuvant treatment of earlvstage breast cancels, a svstematic review recta - analysis of randomized controlled trials 显示文摘	Dahabreh IJ Linardou H Siannis F	2008	Oneologist2008，13，：	1
6	Patent Foramen Ovale Closure and Medical Treatments for Secondary Stroke Prevention: A Systematic Review of Observational and Randomized Evidence显示文摘	Georgios D. Kitsios Issa J. Dahabreh Abd Moain Abu Dabrh David E. Thaler David M. Kent	2012	Stroke2012，，2：	1
7	Patent foramen ovale closure and medical treatments for secondary stroke preven- tion: a systematic review of observational and randomized evidence 显示文摘	Kitsios GD Dahabreh I J Abu-Dabrh AM	2012	Stroke2012，43，：	1
8	Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLC 显示文摘	Linardou H Dahabreh U Bafaloukos D	2009	Nat Rev Clin Oncol2009，6，6：	1
9	Health economics:a cost analysis of treatment of persistent fracture non-unions using bone morphogenetic protein-7显示文摘	Dahabreh Z Dimitriou R Giannoudis PV	2007	Injury2007，38，3：	1
10	Patent Foramen Ovale Closure and Medical Treatments for Secondary Stroke Prevention: A Systematic Review of Observational and Randomized Evidence显示文摘	Georgios D. Kitsios Issa J. Dahabreh Abd Moain Abu Dabrh David E. Thaler David M. Kent	2012	Stroke2012，，2：	1
11	Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLC 显示文摘	Linardou H Dahabreh IJ Bafaloukos D	2009	NatRev Clin Oncol2009，6，6：	1
12	Hematologic manifestations and predictors of lymphoma development in primary Sjogren' s syndrome : clinical path and physiologic aspects 显示文摘	Baimpa E Dahabreh U Voulgarelis M	2009	Medicine ( Balti- more)2009，88，5：	1
13	Heterogeneity of the Phenotypic Definition of Coronary Artery Disease and Its Impact on Genetic Association Studies显示文摘	Georgios D. Kitsios Issa J. Dahabreh Thomas A. Trikalinos Christopher H. Schmid Gordon S. Huggins David M. Kent	2011	Circulation: Cardiovascular Genetics2011，，：	1
14	EGFR gene copy number as a predictive biomarker for patients receiving tyrosine kinase inhibitor treatment:a systematic review and meta analysis in non-small-cell lung cancer显示文摘	Dahabreh I J Linardou H Kosmidis P	2011	Ann Oncol2011，22，3：	1
15	Assessment of somatic K-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer显示文摘	Linardou H Dahabreh IJ Kanaloupiti D	2008	Lancet Oncol2008，9，10：	1
16	Pseudo-bartter syndrome, pattern and correla- tion with other cystic fibrosis features 显示文摘	Dahabreh MM Najada AS	2013	Saudi J Kidney Dis Transpl2013，24，2：	1
17	Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLC 显示文摘	Linardou H Dahabreh I J Bafaloukos D et at	2009	Nat Rev Clin Oncol2009，6，6：	1
18	Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents:a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer显示文摘	Linardou H Dahabreh IJ Kanaloupiti D		0，，10：	1
19	System- atic review: Anti- epidermal growth factor receptor treatment ef- fect modification by KRAS mutations in advanced colorectal cancer显示文摘	DAHABREH IJ TERASAWA T CASTALDI PJ	2011	Annals of Internal Medicine2011，154，1：	1
20	Assessment of somat- ic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer显示文摘	Linardou H Dahabreh IJ Kanaloupiti D	2008	Lancet Oncol2008，9，10：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示